Splenogonadal fusion-limb defects-micrognathia syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2063OMIM:183300Q87.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Splenogonadal fusion-limb defects-micrognathia syndrome (Orphanet code 2063) is an extremely rare congenital malformation syndrome characterized by the abnormal fusion of splenic tissue with gonadal tissue (splenogonadal fusion), limb defects, and micrognathia (an abnormally small jaw). This condition predominantly affects males, as the splenogonadal fusion typically involves the testis, though rare cases involving ovarian tissue have been described. The limb anomalies can range from limb reduction defects to more complex malformations of the extremities. Additional features may include cryptorchidism (undescended testes) and other congenital anomalies. Splenogonadal fusion occurs when splenic and gonadal tissues become abnormally connected during embryonic development, and it can be continuous (with a cord of tissue connecting the spleen to the gonad) or discontinuous (with ectopic splenic tissue attached to the gonad without a connecting cord). The combination with limb defects and micrognathia distinguishes this syndrome from isolated splenogonadal fusion. The condition is typically identified at birth or during early childhood, often incidentally during surgery for cryptorchidism or inguinal hernia, or when limb and facial anomalies prompt further investigation. There is no specific curative treatment for this syndrome. Management is supportive and symptomatic, focusing on surgical correction of limb defects, management of cryptorchidism, orthopedic interventions, and craniofacial care for micrognathia when it causes feeding or breathing difficulties. Awareness of this condition is important to avoid unnecessary orchiectomy, as the splenogonadal fusion mass can be mistaken for a testicular tumor. Fewer than 200 cases of splenogonadal fusion have been reported in the medical literature overall, and the subset with the full triad of limb defects and micrognathia is even rarer.

Also known as:

Clinical phenotype terms— hover any for plain English:

Upper limb asymmetryHP:0100560
Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Splenogonadal fusion-limb defects-micrognathia syndrome.

View clinical trials →

No actively recruiting trials found for Splenogonadal fusion-limb defects-micrognathia syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Splenogonadal fusion-limb defects-micrognathia syndrome community →

No specialists are currently listed for Splenogonadal fusion-limb defects-micrognathia syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Splenogonadal fusion-limb defects-micrognathia syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Splenogonadal fusion-limb defects-micrognathia syndromeForum →

No community posts yet. Be the first to share your experience with Splenogonadal fusion-limb defects-micrognathia syndrome.

Start the conversation →

Latest news about Splenogonadal fusion-limb defects-micrognathia syndrome

No recent news articles for Splenogonadal fusion-limb defects-micrognathia syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Splenogonadal fusion-limb defects-micrognathia syndrome

What is Splenogonadal fusion-limb defects-micrognathia syndrome?

Splenogonadal fusion-limb defects-micrognathia syndrome (Orphanet code 2063) is an extremely rare congenital malformation syndrome characterized by the abnormal fusion of splenic tissue with gonadal tissue (splenogonadal fusion), limb defects, and micrognathia (an abnormally small jaw). This condition predominantly affects males, as the splenogonadal fusion typically involves the testis, though rare cases involving ovarian tissue have been described. The limb anomalies can range from limb reduction defects to more complex malformations of the extremities. Additional features may include crypto

How is Splenogonadal fusion-limb defects-micrognathia syndrome inherited?

Splenogonadal fusion-limb defects-micrognathia syndrome follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Splenogonadal fusion-limb defects-micrognathia syndrome typically begin?

Typical onset of Splenogonadal fusion-limb defects-micrognathia syndrome is neonatal. Age of onset can vary across affected individuals.